Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Dividend Declaration

4 Nov 2022 08:30

RNS Number : 2140F
British Smaller Companies VCT2 Plc
04 November 2022
 

British Smaller Companies VCT2 plc ("the Company")

Special Dividend

 

The directors of British Smaller Companies VCT2 plc ("BSC2" or the "Company") are pleased to announce the payment of a special dividend, which will be the first interim dividend for the year ending 31 December 2023 of 2.25 pence per ordinary share ("Special Dividend").

 

The payment of the Special Dividend follows the successful exits from two separate investments in Springboard and Intelligent Office.

 

Springboard is a leading provider of performance insights for the retail industry across Europe and North America. BSC2 realised its investment in Springboard in September 2022, generating proceeds of £5.8 million, representing a capital profit over cost of £3.9 million, an uplift of 46.0 per cent or £1.8 million on the carrying value at the beginning of the Company's financial year. Including income, the total return from this investment was £6.6 million over a nearly eight year holding period, producing an internal rate of return of 23 per cent and a multiple of 4.1x cost. There is the prospect of further consideration in 2023 based on performance targets, however no value has been taken on these payments at this time.

 

Intelligent Office is a leading provider of support services to the legal sector, with more than 9,000 employees in over 60 client sites across the UK. BSC2 realised its investment in Intelligent Office in September 2022, generating proceeds of £4.1 million, representing a capital profit over cost of £2.1 million, an uplift of 29.0 per cent or £0.9 million on the carrying value at the beginning of the year. Including income, the total return from this investment was £5.0 million over an eight and a half year holding period, producing an internal rate of return of 14 per cent and a multiple of 2.6x cost.

 

The Special Dividend will be paid on 11 January 2023 to those shareholders on the Company's register at the close of business on 18 November 2022. The ex-dividend date will be 17 November 2022. The Special Dividend will reduce the net asset value by 2.25 pence per ordinary share.

 

The Company operates a dividend re-investment scheme ("DRIS"). The latest date for receipt of new or updated DRIS elections in respect of the Special Dividend is the close of business on 2 December 2022.

 

4 November 2022

 

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPFDELFAFEA
Date   Source Headline
16th Apr 201011:52 amRNSCirc re. Offer for Subscription
7th Apr 20103:50 pmRNSDoc re. Annual Report for year to 31 December 2009
6th Apr 20102:56 pmRNSIssue of Equity
24th Mar 20107:00 amRNSAnnual Financial Report to 31 December 2009
2nd Feb 20107:00 amRNSStatement re proposed fundraising
16th Nov 20091:19 pmRNSInterim Management Statement
24th Sep 20091:28 pmRNSDividend Declaration
22nd Sep 20099:11 amRNSStatement re holding in DxS Ltd
26th Aug 20099:24 amRNSHalf Yearly Report to 30 June 2009
19th May 20091:36 pmRNSInterim Management Statement
14th May 20093:02 pmRNSAGM Statement
30th Apr 200910:45 amRNSAnnual Financial Report & Dividend
23rd Mar 20091:12 pmRNSUnaudited Preliminary Results
19th Nov 200810:48 amRNSInterim Management Statement
5th Nov 200810:34 amRNSDirector Shareholding
29th Aug 200810:16 amRNSHalf Yearly Report
20th Aug 200812:03 pmRNSInterim Results
1st Jul 200810:01 amRNSDirector Change
19th May 20084:17 pmRNSInterim Management Statement
14th May 20081:28 pmRNSAGM Statement
8th May 200810:57 amRNSAnnual Report and Accounts
29th Apr 20089:08 amRNSHolding in Sarian Systems Ltd
4th Apr 20081:20 pmRNSStatement re Fund Manager
1st Apr 20084:31 pmRNSFinal Results
17th Dec 20075:15 pmRNSNet Asset Value(s)
17th Dec 20073:38 pmRNSDirectorate Change
23rd Oct 20079:00 amRNSDividend Declaration
6th Sep 20079:36 amRNSAnnouncement re Cozart plc
5th Sep 20075:06 pmRNSSale of holding in Cozart plc
14th Aug 200711:14 amRNSInterim Results
24th May 20078:45 amRNSNet Asset Value(s)
16th Apr 200710:46 amRNSFurther re Final Results
3rd Apr 200710:42 amRNSFinal Results
2nd Jan 20077:01 amRNSMerger Update
22nd Dec 200611:55 amRNSTransparency Directive
19th Dec 200610:07 amRNSNet Asset Value(s)
25th Oct 20067:00 amRNS3rd Qtr Financial Statements
24th Oct 20066:02 pmRNS3rd Quarter Results
29th Sep 200610:15 amRNSRealisation of Vibration Tech
26th Sep 20067:00 amRNSDividend Declaration
4th Aug 20064:10 pmRNSInterim Results
24th Jul 20063:12 pmRNSInterim Results
12th Jul 20069:11 amRNSAGM Statement
28th Jun 20063:28 pmRNSMerger Update
26th Jun 20066:10 pmRNSDividend Declaration
15th Jun 200612:00 pmRNSMerger Update
23rd May 20065:24 pmRNSWithdrawal of Buy Back Policy
12th May 20069:53 amRNSNet Asset Value(s)
11th May 200611:18 amRNSPurchase of Own Shares
27th Apr 20061:53 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.